MedTrace Logo

Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability

NCT00628199 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-08-12

No results posted yet for this study

Summary

This is a research study in which your cells will be used for somatic cell nuclear transfer (SCNT), and/or genetic reprogramming research which may result in the production of stem cell lines. This study does not provide treatment.

Conditions

Interventions

PROCEDURE

Improving the scientific process of human cell reprogramming

Sponsors & Collaborators

Principal Investigators

  • Marius Wernig, MD · Stanford University

Eligibility

Min Age
1 Year
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2030-01-31
Completion
2030-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00628199 on ClinicalTrials.gov